Mark Hillsdon looks at an innovative public-private partnership that has been working to improve global health outcomes since 2001 but has seen vaccination rates stall
The access agenda isn’t just about making drugs freely available in developing countries, Mark Hillson reports. Pharmaceutical companies are trying to tackle the dearth of trained health workers, particularly in sub-Saharan Africa
Joe Jimenez, CEO of pharmaceutical multinational Novartis, speaks to Ethical Corporation about corporate innovation and the importance of a sustainable business approach